Peptides for nucleic acid delivery

被引:180
作者
Lehto, Taavi [1 ,2 ]
Ezzat, Kariem [1 ]
Wood, Matthew J. A. [3 ]
EL Andaloussi, Samir [1 ,3 ]
机构
[1] Karolinska Inst, Dept Lab Med, SE-17177 Stockholm, Sweden
[2] Univ Tartu, Inst Technol, Nooruse 1, EE-50411 Tartu, Estonia
[3] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England
基金
瑞典研究理事会;
关键词
Cell-penetrating peptides; Nucleic acid delivery; Oligonucleotides; Antisense oligonucleotides; siRNA; Nanoparticles; Splice-switching oligonucleotides; Delivery peptides; CELL-PENETRATING-PEPTIDES; ANTISENSE MORPHOLINO OLIGOMERS; DUCHENNE MUSCULAR-DYSTROPHY; RECEPTOR-MEDIATED UPTAKE; IN-VIVO; SIRNA DELIVERY; GENE DELIVERY; INTRACELLULAR TRAFFICKING; OLIGONUCLEOTIDE DELIVERY; ANTENNAPEDIA HOMEODOMAIN;
D O I
10.1016/j.addr.2016.06.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nucleic acids and their synthetic oligonucleotide (ON) analogs are a group of gene therapeutic compounds which hold enormous clinical potential. Despite their undoubted potential, clinical translation of these molecules, however, has been largely held back by their limited bioavailability in the target tissues/cells. To overcome this, many different drug delivery systems have been devised. Among others, short delivery peptides, called cell-penetrating peptides (CPPs), have been demonstrated to allow for efficient delivery of nucleic acids and their ON analogs, in both cell culture and animal models. In this review, we provide brief overview of the latest advances in nucleic acid delivery with CPPs, covering the two main vectorization strategies, covalent conjugation and nanoparticle formation-based approach. In conclusion, CPP-based drug delivery systems have the capacity to overcome the hurdle of delivery and thus have the potential to facilitate the clinical translation of nucleic acid-based therapeutics. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:172 / 182
页数:11
相关论文
共 123 条
[1]   Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies [J].
Abes, Rachida ;
Moulton, Hong M. ;
Clair, Philippe ;
Yang, Sung-Tae ;
Abes, Said ;
Melikov, Kamran ;
Prevot, Paul ;
Youngblood, Derek S. ;
Iversen, Patrick L. ;
Chernomordik, Leonid V. ;
Lebleu, Bernard .
NUCLEIC ACIDS RESEARCH, 2008, 36 (20) :6343-6354
[2]   Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents [J].
Abes, Said ;
Moulton, Hong M. ;
Clair, Philippe ;
Prevot, Paul ;
Youngblood, Derek S. ;
Wu, Rebecca P. ;
Iversen, Patrick L. ;
Lebleu, Bernard .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (03) :304-313
[3]   Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo [J].
Andaloussi, Samir E. L. ;
Lehto, Taavi ;
Maeger, Imre ;
Rosenthal-Aizman, Katri ;
Oprea, Iulian I. ;
Simonson, Oscar E. ;
Sork, Helena ;
Ezzat, Kariem ;
Copolovici, Dana M. ;
Kurrikoff, Kaido ;
Viola, Joana R. ;
Zaghloul, Eman M. ;
Sillard, Rannar ;
Johansson, Henrik J. ;
Hassane, Fatouma Said ;
Guterstam, Peter ;
Suhorutsenko, Julia ;
Moreno, Pedro M. D. ;
Oskolkov, Nikita ;
Haelldin, Jonas ;
Tedebark, Ulf ;
Metspalu, Andres ;
Lebleu, Bernard ;
Lehtioe, Janne ;
Smith, C. I. Edvard ;
Langel, Uelo .
NUCLEIC ACIDS RESEARCH, 2011, 39 (09) :3972-3987
[4]   Differential Endosomal Pathways for Radically Modified Peptide Vectors [J].
Arukuusk, Piret ;
Paernaste, Ly ;
Margus, Helerin ;
Eriksson, N. K. Jonas ;
Vasconcelos, Luis ;
Padari, Kaert ;
Pooga, Margus ;
Langel, Ulo .
BIOCONJUGATE CHEMISTRY, 2013, 24 (10) :1721-1732
[5]   The Promise of MicroRNA Replacement Therapy [J].
Bader, Andreas G. ;
Brown, David ;
Winkler, Matthew .
CANCER RESEARCH, 2010, 70 (18) :7027-7030
[6]   Heparan sulfate proteoglycan as a plasma membrane carrier [J].
Belting, M .
TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (03) :145-151
[7]   Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA) [J].
Bendifallah, Nadia ;
Rasmussen, Frank Winther ;
Zachar, Vladimir ;
Ebbesen, Peter ;
Nielsen, Peter E. ;
Koppelhus, Uffe .
BIOCONJUGATE CHEMISTRY, 2006, 17 (03) :750-758
[8]   RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform [J].
Bennett, C. Frank ;
Swayze, Eric E. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2010, 50 :259-293
[9]   Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model [J].
Bestas, Burcu ;
Moreno, Pedro M. D. ;
Blomberg, K. Emelie M. ;
Mohammad, Dara K. ;
Saleh, Amer F. ;
Sutlu, Tolga ;
Nordin, Joel Z. ;
Guterstam, Peter ;
Gustafsson, Manuela O. ;
Kharazi, Shabnam ;
Piatosa, Barbara ;
Roberts, Thomas C. ;
Behlke, Mark A. ;
Wood, Matthew J. A. ;
Gait, Michael J. ;
Lundin, Karin E. ;
El Andaloussi, Samir ;
Mansson, Robert ;
Berglof, Anna ;
Wengel, Jesper ;
Smith, C. I. Edvard .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (09) :4067-4081
[10]  
Betts C.A., 2015, SCI REP, V5